During the past decade, Ospedale Ferrarotto conducted 6 clinical trials. In the 10-year time frame, 6 clinical trials started and 8 clinical trials were completed, i.e. on average, 133.3% percent of trials that started reached the finish line to date. In the past 5 years, 1 clinical trials started and 6 clinical trials were completed. i.e. 600% of trials that started reached the finish line.

Out of the total clinical trials conducted in "Ospedale Ferrarotto" #1 sponsor was "Gruppo Italiano Malattie EMatologiche dell'Adulto" with 9 trials, followed by "Celgene" with 5 trials sponsored, "European Organisation for Research and Treatment of Cancer - EORTC" with 5 trials sponsored, "Associazione Qol-one" with 3 trials sponsored and "Boston Scientific Corporation" with 3 trials sponsored. Other sponsors include 7 different institutions and companies that sponsored additional 17 trials in total.

In terms of collaborators to trials, out of the total clinical trials conducted in "Ospedale Ferrarotto" #1 collaborator was "Gruppo Italiano Malattie EMatologiche dell'Adulto" with 3 trials as a collaborator, "Acute Leukemia French Association" with 1 trials as a collaborator, "Azienda Policlinico Umberto I" with 1 trials as a collaborator, "European Commission" with 1 trials as a collaborator and "Meditrial SrL" with 1 trials as a collaborator. Other collaborators include -3 different institutions and companies that were collaborators in the rest 7 trials.

According to Clinical.Site data, the most researched conditions in "Ospedale Ferrarotto" are "Leukemia" (7 trials), "Multiple Myeloma" (4 trials), "Myelodysplastic Syndromes" (3 trials), "Chronic Myeloid Leukemia" (2 trials) and "Acute Myeloid Leukemia" (1 trials). Many other conditions were trialed in "Ospedale Ferrarotto" in a lesser frequency.

Most popular intervention types in "Ospedale Ferrarotto" are "Drug" (25 trials), "Procedure" (8 trials), "Other" (6 trials), "Radiation" (4 trials) and "Device" (3 trials). Other intervention types were less common.

The name of intervention was led by "mitoxantrone hydrochloride" (5 trials), "Placebo" (4 trials), "cytarabine" (4 trials), "etoposide" (4 trials) and "idarubicin" (4 trials). Other intervention names were less common.

The vast majority of trials in "Ospedale Ferrarotto" are 36 trials for "All" genders.

Currently, there are NaN active trials in "Ospedale Ferrarotto". undefined are not yet recruiting, undefined are recruiting, 2 are Active, not recruiting, and undefined are Enrolling by invitation. In total, there were 25 completed trials in Ospedale Ferrarotto, 1 suspended trials, and 3 terminated clinical trials to date.

Out of the total trials that were conducted in Ospedale Ferrarotto, 0 "Phase 1" clinical trials were conducted, 12 "Phase 2" clinical trials and 14 "Phase 3" clinical trials were conducted as well. "Phase 4" trials included 2 trials, and there were also 1 trials that are defined as “Not Applicable".